EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

The Diagnostic Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-Analysis

Ji-In Bang, Sohyun Park, Keunyoung Kim iD, Youngduk Seo, Ari Chong, Chae Moon Hong iD, Miyoung Choi iD, Sang-Woo Lee, So Won Oh iD

Thyroid® · 2023-10 · 33 (10) · 1224-1236

DOI: 10.1089/thy.2023.0264 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Thyroid®, online erschienen am 13.10.2023. Verfasst von Ji-In Bang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, CHA Bundang Medical Center, CHA University, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Iodine, Thyroid Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study is to evaluate the diagnostic accuracy of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in detecting recurrence in patients with differentiated thyroid cancer (DTC) who have negative whole-body scans (WBSs) but elevated serum thyroglobulin (Tg) or thyroglobulin antibody (TgAb) levels.

Methods

This systematic review/meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis for Diagnostic Test Accuracy criteria (International Prospective Register of Systematic Reviews registration number: CRD42022340924). A comprehensive search of the MEDLINE, EMBASE, and Cochrane databases identified articles reporting the diagnostic accuracy of FDG PET/CT for the detection of recurrence in patients with DTC with negative WBS and elevated serum Tg or TgAb levels published between January 2012 and June 2023. Meta-analyses were performed to determine the diagnostic accuracy of FDG PET/CT on the total target population as well as on subgroups stratified by serum Tg or TgAb, and thyrotropin (TSH) stimulation status at the time of FDG PET/CT. The Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) framework was applied to evaluate the quality of evidence and the strength of recommendations to facilitate translation of the meta-analysis results into practical recommendations for clinical guidelines.

Results

A total of 24 studies involving 1988 patients were included for analysis. The overall pooled sensitivity and specificity values were 0.87 (95% confidence interval [CI] = 0.83–0.92; I 2 = 75%) and 0.84 (CI = 0.80–0.89; I 2 = 44%), respectively. Subgroup analyses revealed no significant differences in the diagnostic accuracy of FDG PET/CT in patients stratified by serum Tg or TgAb levels, and TSH stimulation status at the time of PET/CT. Treatment plans were changed following FDG PET/CT imaging in 40% (CI = 34–47%; I 2 = 39%) of cases. The quality level of evidence for using FDG PET/CT was moderate in both sensitivity and specificity according to the GRADE system.

Conclusion

There is moderate quality evidence demonstrating the high diagnostic accuracy of FDG PET/CT in detecting recurrence in patients with DTC with negative WBS and elevated serum Tg or TgAb levels. This evidence corroborates the current guidelines' endorsement of FDG PET/CT as a diagnostic tool in such patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IodineThyroid NeoplasmsAdenocarcinomaHumansPositron Emission Tomography Computed TomographyThyroglobulinFluorodeoxyglucose F18Positron-Emission TomographyIodine RadioisotopesThyrotropin

Stichwörter der Autor:innen

18F-fluorodeoxyglucosemeta-analysispositron emission tomography/computed tomographythyroglobulinthyroid cancer

Substanzen

ThyroglobulinFluorodeoxyglucose F18IodineIodine RadioisotopesThyrotropin

Autor:innen und Institutionen

  • Department of Nuclear Medicine, CHA Bundang Medical Center, CHA University, Gyeonggi-do, Republic of Korea.
  • Department of Nuclear Medicine, National Cancer Center Hospital, Gyeonggi-do, Republic of Korea.
  • Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital and School of Medicine, Pusan National University, Pusan, Republic of Korea.
  • Department of Nuclear Medicine, Chungnam National University Sejong Hospital, Sejong, Korea.
  • Department of Nuclear Medicine, College of Medicine, Chosun University, Gwangju, Korea.
  • Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

ORCID-Profile: Keunyoung Kim, Chae Moon Hong, Miyoung Choi, So Won Oh

Förderung

  • National Cancer Center

Zitieren

APA

Bang, J. I., Park, S., Kim, K., Seo, Y., Chong, A., Hong, C. M., Choi, M., Lee, S. W., & Oh, S. W. (2023). The Diagnostic Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-Analysis. Thyroid®, 33(10), 1224-1236. https://doi.org/10.1089/thy.2023.0264

Vancouver

Bang JI, Park S, Kim K, Seo Y, Chong A, Hong CM, et al. The Diagnostic Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-Analysis. Thyroid®. 2023;33(10):1224-1236. doi:10.1089/thy.2023.0264

BibTeX
@article{Bang2023,
  author = {Bang, Ji-In and Park, Sohyun and Kim, Keunyoung and Seo, Youngduk and Chong, Ari and Hong, Chae Moon and Choi, Miyoung and Lee, Sang-Woo and Oh, So Won},
  title = {The Diagnostic Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-Analysis},
  journal = {Thyroid®},
  year = {2023},
  volume = {33},
  number = {10},
  pages = {1224--1236},
  doi = {10.1089/thy.2023.0264}
}
Kostenlos starten →